Bahia Mar
The Point Distillery, LLC — New Port Richey, FL
Florida
About Bahia Mar
Bahia Mar is a flavored rum produced in Florida and registered with the Alcohol and Tobacco Tax and Trade Bureau. The brand carries a classification as "rum other flavored," indicating it falls within the category of rum-based spirits with added flavoring. According to TTB public records, Bahia Mar maintains a single distinct product offering currently tracked in the spirits marketplace. The brand received its initial TTB label approval in 2024, marking its entry into the federally regulated spirits market. As a Florida-based rum producer, Bahia Mar operates within a state with a significant tradition in rum manufacturing and distribution. The spirit's categorization as a flavored rum positions it within a broad category that encompasses various infused and flavored rum products available to consumers. With approval documentation on file with federal regulatory authorities, Bahia Mar represents a registered entry in the comprehensive database of spirits products legally produced and distributed in the United States. The brand's single approved label configuration suggests a focused product line at its current market stage.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Bahia Mar RUM OTHER FLAVORED | Rum Other Flavored | Approved | 2024-12-30 | The Point Distillery, LLC |
Page 1 of 1
Bahia Mar at a Glance
Bahia Mar has 1 distinct product with 1 total TTB label approvals, including Rum Other Flavored. Labels approved between 2024-12-30 and 2024-12-30. Produced in Florida.
All information sourced from public TTB records.
Are you the owner or distributor of Bahia Mar?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
The Point Distillery, LLCRelated Brands
- Muscle also from Florida
- Three Olives also from Florida
- Florida Cane also from Florida
- Ice Pik also from Florida
- Dark Door Spirits also from Florida
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.